Search results
Table 1. Eight Key Clinical Management Issues Related to the Management of Patients at Risk for and With LV Thrombus. Is echocardiography adequate for detection of suspected LV thrombus, or is CMR (or cardiac CT) indicated when there is concern for LV thrombus?
Abstract. Introduction Left ventricular thrombus (LVT) is a frequent complication of left ventricular systolic dysfunction (1). Incidence following acute myocardial infarction is estimated at 13–20% and up to 15% in with non-ischaemic cardiomyopathy (2, 3). Once diagnosed, guidelines recommend anticoagulation with vitamin K antagonists (VKA ...
Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.
14 wrz 2022 · Is anticoagulation really indicated for laminated thrombus (not a more mobile, round, mural thrombus)? Is DOAC a reasonable alternative to warfarin for the prevention and treat-ment of LV thrombus? What management options are there in patients with persistent LV throm-bus despite therapy?
23 wrz 2022 · The following are key points to remember about this scientific statement from the American Heart Association (AHA) for the management of patients at risk for and with left ventricular (LV) thrombus: Decisions concerning the diagnosis, prevention, and treatment of LV thrombus remain challenging.
Management of LV thrombus (LVT) is challenging and crucial to prevent the potential development of thromboembolic complications such as stroke. Anticoagulation with warfarin is recommended for the prevention of thromboembolic events, but novel oral anticoagulants (NOAC) have been used in clinical practice without supporting evidence.
Left ventricular (LV) thrombus is a feared complication of LV dysfunction associated with high rates of systemic embolism, morbidity, and mortality. Traditionally, LV thrombus has been associated with acute myocardial infarction (MI).
